Table 2 Data on treatment and clinical evolution at first year
Patient | Onset of HFR since diagnosis (days) | Onset of QT since diagnosis (days) | Mean serum FLC reduction (%) | Mean serum Albumin levels pre dialysis (mmol/L) | Mean serum Albumin levels post dialysis (mmol/L) | Number of Supra HFR sessions | Renal recovery | State |
|---|---|---|---|---|---|---|---|---|
1 | 0 | 7 | 63 | 0.52 | 0.53 | 40 | No | D |
2 | 0 | 0 | 72 | 0.37 | 0.35 | 36 | Yes | A |
3 | 3 | 7 | 24 | – | – | 24 | Yes | A |
4 | 0 | 4 | 54 | 0.43 | 0.40 | 36 | Yes | A |
5 | 0 | 0 | 26 | 0.42 | 0.41 | 40 | No | D |
6 | 0 | 3 | 70 | – | – | 38 | No | A |
7 | 0 | 11 | 47 | – | – | 38 | No | A |
8 | 0 | 0 | 52 | – | – | 38 | No | A |
9 | 3 | 1 | 14 | – | – | 38 | No | A |
MEAN: | 0.67 ± 1.32 | 3.67 ± 3.93 | 57.6 ± 10 (κ) 33.5 ± 25 (λ) | 0.43 ± 0.06 | 0.42 ± 0.07 | 36 ± 4 | ||
10 | 0 | 0 | 30 | 0.44 | 0.39 | 38 | No | A |
11 | 0 | 3 | 32 | 0.50 | 0.49 | 12 | Yes | A |